ERS International Congress, Paris 2018

Browse by day: Saturday, 15.09.2018 Sunday, 16.09.2018 Monday, 17.09.2018 Tuesday, 18.09.2018 Wednesday, 19.09.2018		View the presentations you missed during Congress! More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.

Mesothelioma and pleural malignancy: investigations and management

Thematic Poster
Chairs: J. Janssen (Nijmegen, Netherlands), M. Munavvar (Preston (Lancashire), United Kingdom), R. Krenke (Laski, Poland), S. Zarogiannis (Larisa, Greece)

Download all media

5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin G. Stella (Pavia, Italy), M. Bosio (Pavia, Italy), E. Salvaterra (Pavia, Italy), P. Morbini (Pavia, Italy), M. Zorzetto (Pavia, Italy), S. Inghilleri (Pavia, Italy), S. Tomaselli (Pavia, Italy), P. Mangiarotti (Pavia, Italy), F. Datturi (Pavia, Italy), F. Meloni (Pavia, Italy), I. Cerveri (Pavia, Italy)
In the era of personalised medicine, is pleural fluid cytology sufficient for oncological treatment? R. Mercer (Oxford, United Kingdom), D. Mccracken (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
Targeting of CSF1R abrogates Lewis Lung adenocarcinoma-induced malignant pleural effusion S. Magkouta (ATHENS, Greece), C. Kosti (ATHENS, Greece), P. Vaitsi (ATHENS, Greece), A. Pappas (ATHENS, Greece), C. Moschos (ATHENS, Greece), M. Iliopoulou (ATHENS, Greece), K. Psarra (ATHENS, Greece), I. Kalomenidis (ATHENS, Greece)
Treatment with Anti-VEGF and anti-EGFR in a model of malignant pleural effusion: Genic evaluation L. Ribeiro Teixeira (Sao Paulo, Brazil), V. Alvarenga (Sao Paulo, Brazil), R. Sales (Sao Paulo, Brazil), C. Silva (Sao Paulo, Brazil), N. Almeida (Sao Paulo, Brazil), L. Sousa (Sao Paulo, Brazil), A. Santos (Sao Paulo, Brazil), V. Capelozzi (Sao Paulo, Brazil), E. Marchi (Sao Paulo, Brazil), M. Acencio (Sao Paulo, Brazil)
Role of markers C-Reactive Protein, Procalcitonin and TREM-1 in diagnosis of infection pleural effusion V. Alvarenga (Sao Paulo, Brazil), M. Acencio (Sao Paulo, Brazil), R. Sales (Sao Paulo, Brazil), A. Silva (Sao Paulo, Brazil), J. Silva (Sao Paulo, Brazil), C. Silva (Sao Paulo, Brazil), L. Ribeiro Teixeira (Sao Paulo, Brazil), E. Marchi (Sao Paulo, Brazil)
Water and urea transport in benign and malignant pleural mesothelial cells. E. Solenov (Novosibirsk, 630090 , Russian Federation), A. Ershov (Novosibirsk, 630090 , Russian Federation), G. Baturina (Novosibirsk, 630090 , Russian Federation), L. Katkova (Novosibirsk, 630090 , Russian Federation), C. Hatzoglou (BIOPOLIS, Larissa 41110, Greece), K. Gourgoulianis (BIOPOLIS, Larissa 41110, Greece), S. Zarogiannis (BIOPOLIS, Larissa 41110, Greece)
ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness C. Sepult (Liege, Belgium), M. Bellefroid (Liege, Belgium), C. Gilles (Liege, Belgium), A. Ludwig (Aachen, Germany), B. Duysinx (Liege, Belgium), A. Noel (Liege, Belgium), D. Cataldo (Liege, Belgium)
Effects of 2-Deoxy-glucose with Cisplatin-Pemetrexed in mesothelioma sphere formation. R. Jagirdar (Larissa, Greece), I. Georgianni (Larissa, Greece), E. Pitaraki (Larissa, Greece), E. Papazoglou (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece)
Cytology, chest computed and positron emission tomography correlations in lung cancer malignant pleural effusion. C. Brun (Saint-Etienne, France), P. Gay (Saint-Etienne, France), M. Cottier (Saint-Etienne, France), G. Karpathiou (Saint-Etienne, France), F. Barral (Saint-Etienne, France), J. Vergnon (Saint-Etienne, France), M. Froudarakis (Saint-Etienne, France)
Investigating unilateral pleural effusions: the role of cytology. D. Arnold (Bristol, United Kingdom), D. De Fonseka (Bristol, United Kingdom), S. Perry (Bristol, United Kingdom), A. Medford (Bristol, United Kingdom), M. Brett (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom)
The use of immunocytochemistry to diagnose the etiology of malignant pleural effusion. V. Klimenko (Saint-Petersburg, Russian Federation), A. Reshetov (Saint-Petersburg, Russian Federation), V. Novik (Saint-Petersburg, Russian Federation), O. Ivanov (Saint-Petersburg, Russian Federation), D. Ermakov (Saint-Petersburg, Russian Federation)
Red cell distribution width value as a novel biomarker for exudative pleural fluid. A. Sharifi (Tabriz,, Islamic Republic of Iran), D. Amir (Tabriz,, Islamic Republic of Iran)
Differences in the pathological patterns of non-specific pleuritis (NSP). G. Karpathiou (Saint-Etienne, France), S. Hathroubi (Saint-Etienne, France), A. Patoir (Saint-Etienne, France), O. Tiffet (Saint-Etienne, France), F. Casteillo (Saint-Etienne, France), C. Brun (Saint-Etienne, France), F. Forest (Saint-Etienne, France), N. Rahman (Oxford, United Kingdom), M. Peoc'H (Saint-Etienne, France), M. Froudarakis (Saint-Etienne, France)
Comparison of pleural fluid pH measurements: blood gas analyzer, pH indicator stick, litmus paper, and point-of-care testing for blood gases S. Kim (Wonju, Republic of Korea), B. Shin (Wonju, Republic of Korea), S. Lee (Wonju, Republic of Korea), M. Lee (Wonju, Republic of Korea), W. Lee (Wonju, Republic of Korea), S. Yong (Wonju, Republic of Korea)
Impact of a pleural pathology unit in a third level hospital I. Ruiz Alvarez (Oviedo, Spain), F. Lopez Gonzalez (Oviedo, Spain), A. Enriquez Rodriguez (Cangas del Narcea, Spain), T. Hermida Valverde (Oviedo, Spain), C. Osoro Suárez (Oviedo, Spain), J. Herrero Huertas (Oviedo, Spain), A. Ortiz Reyes (Oviedo, Spain), A. Moreda Bernanrdo (Oviedo, Spain), L. Garcia Alfonso (Oviedo, Spain), P. Casan Clara (Oviedo, Spain)
Pericardial and pleural metastases: clinical and histological differences G. Karpathiou (Saint-Etienne, France), M. Mobarki (Saint-Etienne, France), S. Hathroubi (Saint-Etienne, France), M. Stachowicz (Saint-Etienne, France), A. Patoir (Saint-Etienne, France), O. Tiffet (Saint-Etienne, France), M. Peoc'H (Saint-Etienne, France), M. Froudarakis (Saint-Etienne, France)
Rotation Aiding (RA’s) technique for EBUS-TBNA biopsy of intrathoracic lymph node: a comparison of conventional Jab method S. Ra (Ulsan, Republic of Korea), W. Kwon (Ulsan, Republic of Korea), Y. Lee (Ulsan, Republic of Korea), C. Park (Ulsan, Republic of Korea), H. Cha? (Ulsan, Republic of Korea), B. Kang (Ulsan, Republic of Korea), T. Lee (Ulsan, Republic of Korea), Y. Jegal (Ulsan, Republic of Korea), J. Ahn (Ulsan, Republic of Korea), Y. Chee (Ulsan, Republic of Korea), K. Seo (Ulsan, Republic of Korea)
Malignant Mesothelioma (MM) is still the leading cause of death in Karain villagers in Turkey and/or abroad due to erionite exposure A. Emri (Istanbul, Turkey), D. Esendagli (Ankara, Turkey), M. Carbone (Honolulu, United States of America)